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Reactive oxygen speciesBackground: Inﬂammation is one of majormechanisms contributing to the pathogenesis ofmyocardial ischemia/
reperfusion (I/R) injury. Pentraxin 3 (PTX3), produced in response to inﬂammatory signals, acts as a humoral
arm of the innate immunity. Here we investigated the role of PTX3 produced from bone marrow-derived cells
in myocardial I/R injury using PTX3-deﬁcient (PTX3KO) mice.
Methods and results: PTX3KO mice and wild-type littermate (WT) mice were lethally irradiated and injected
with bone marrow (BM) cells, generating four types of mice (WTWT-BM, WTPTX3KO-BM, PTX3KOWT-BM and
PTX3KOPTX3KO-BM). Six weeks after BM transplantation, the myocardial I/R procedure (45 min of left descending
coronary artery ligation followed by 48 h of reperfusion) was performed. Infarct size was greater in WT and
PTX3KO mice with BM from PTX3KO donor (WTPTX3KO-BM and PTX3KOPTX3KO-BM) compared with WT and
PTX3KOmicewith BM fromWTdonor (WTWT-BM and PTX3KOWT-BM). Localization of PTX3was observed in neu-
trophils and macrophages in WT and PTX3KO mice with BM from WT donor (WTWT-BM and PTX3KOWT-BM),
while only in endothelial cells inWTmicewith BM fromPTX3KOdonor (WTPTX3KO-BM). Inﬁltration of neutrophils
and generation of reactive oxygen species (ROS) at ischemic border zoneswere greater in PTX3KOmice with BM
from PTX3KO donor (PTX3KOPTX3KO-BM) than PTX3KO mice with BM from WT donor (PTX3KOWT-BM). Plasma
levels and cardiac expressions of interleukin-6 were higher in PTX3KO mice with BM from PTX3KO donor
(PTX3KOPTX3KO-BM) than PTX3KOmice with BM fromWT donor (PTX3KOWT-BM). However, no signiﬁcant differ-
ences in infarct size, inﬁltration of neutrophils, generation of ROS and plasma and cardiac levels of interleukin-6
were observed betweenWTand PTX3KOmicewith BM fromWTdonor and betweenWT and PTX3KOmicewith
BM from PTX3KO donor. These results indicated that the lack of PTX3 produced from BM-derived cells, and not
from cardiac resident cells, exacerbated myocardial injury after I/R.
Conclusion: PTX3 produced from bone marrow-derived cells plays a crucial role in cardiac protection against
myocardial I/R injury by attenuating inﬁltration of neutrophils, generation of ROS and inﬂammatory cytokine.
© 2015 The Authors. Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Although coronary artery reperfusion is currently the most effective
therapy for acute myocardial infarction, the process of restoring blood
ﬂow to the ischemicmyocardium itself can inducemyocardial damages,
also known as myocardial ischemia/reperfusion (I/R) injury. Lethal
reperfusion injury, one of the different clinical manifestations of this
paradoxical phenomenon and characterized as irreversible cell death,
contains several potential mechanisms [1]. Inﬂammation is one of
major mediators contributing to the pathogenesis of lethal reperfusiony and Hematology, Fukushima
Japan.
en access article under the CC BY-NCinjury, including a rapid increase in cytokines and congregation of leu-
kocytes in the injured myocardial region [2]. Neutrophils and mono-
cytes are drawn into the infarct zone by chemoattractants and migrate
intomyocardial tissue during theﬁrst 24 h ofmyocardial I/R.Monocytes
subsequently give rise to reparative macrophages, thereby entering
the resolution phase. These two phases (inﬂammatory and resolution
phase) are essential for infarct healing [3]. However, in the pathogenesis
of I/R injury, neutrophils release degradative enzymes and reactive
oxygen species (ROS) leading to irreversible myocardial damage,
which is a detrimental aspect of inﬂammatory response [4].
Pentraxin 3 (PTX3) belongs to the pentraxin superfamily and is an
essential component of the humoral arm of innate immunity. PTX3 is
expressed by various cell types such as myeloid dendritic cells, neutro-
phils, macrophages, endothelial cells, ﬁbroblasts and smooth muscle-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Analysis of chimeric mouse blood. PCR was performed with DNA extracted from
white blood cells six weeks after bone marrow transplantation. PCR products of 124 bp
were obtained for WT, WTWT-BM and PTX3KOWT-BM, and 300 bp for PTX3KO, WTPTX3KO-BM
and PTX3KOPTX3KO-BM.
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stimuli including inﬂammatory cytokines, Toll-like receptor agonists,
and microbial moieties, with different signaling pathways depending
on cell type and/or stimuli (e.g., NF-κB pathway in the acute myocardial
ischemia model, c-Jun. N-terminal kinase pathway in lung epithelial
cells, and PI3K/Akt pathway in endothelial cells). Physiological functions
of PTX3 are associated with the recognition and binding to different
ligands; PTX3 modulates complement pathways by binding with com-
plement component C1q, supports clearance of recognized pathogens
by opsonization or phagocytosis, and inhibits leukocyte recruitment
by interacting with P-selectin [6].
Several reports have described the cardiovascular protective [7,8]
or detrimental [9] effects of PTX3 using genetically manipulated mice,
indicating that PTX3 is potentially associated with the immunoinﬂam-
matory response observed in several cardiovascular diseases. Salio
et al. [7] have revealed a cardio-protective role of PTX3 in myocardial
I/R mouse model. In that report, they also elucidated that PTX3, which
was expressed and/or produced in both leukocytes and cardiac resident
cells, suppressed the no-reﬂow phenomenon and leukocyte inﬁltration
in myocardial I/R injury. However, the origins of PTX3 functioning for
protection of myocardium was unclear.
In this study, we investigated the role of PTX3 produced from bone
marrow-derived cells inmyocardial I/R injury using PTX3 deﬁcientmice.2. Material and methods
2.1. Animals and ethics statement
PTX3-deﬁcient (PTX3KO) mice and wild-type littermate (WT) mice
(C57BL/6, male) were used for the experiments. PTX3KOmice were gen-
erated as previously described [10]. All experimental procedures were
performed according to the animal welfare regulations of Fukushima
Medical University, and the study protocol was approved by the
Fukushima Medical University Animal Research Committee. The investi-
gations conformed to the Guidelines for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH publica-
tion, 8th Edition, 2011).2.2. Bone marrow transplantation
PTX3KO andWTmice between 10 and 12 weeks of age were lightly
anesthetized by titrating isoﬂurane (0.5–1.5%) and sacriﬁced via cervi-
cal dislocation. Whole bone marrow (BM) cells were harvested by
ﬂushing femurs with phosphate-buffered saline (PBS), as previously
reported [11]. The cells were washed twice with PBS and diluted to
5.0 × 106 cell/200 μL with saline. The recipient mice (8 weeks of age)
were lethally irradiated with a total dose of 9 Gy and were injected
with BM cells through the tail vein. Using this protocol, we produced
four types of BM transplantation mice: WT-BM to WT recipient
mice (WTWT-BM), PTX3KO-BM to WT recipient mice (WTPTX3KO-BM),
WT-BM to PTX3KO recipient mice (PTX3KOWT-BM), and PTX3KO-
BM to PTX3KO recipient mice (PTX3KOPTX3KO-BM). To conﬁrm the en-
graftment of donor BM cells in the recipients, we extracted DNA from
white blood cells and analyzed the genotypes. Blood samples were
obtained from the retro-orbital plexus of recipient mice 6 weeks
after BM transplantation, and DNA was isolated using the QIAamp
DNAMini Kit (Qiagen, Valencia, CA) according to the manufacturer's
instructions. PCR was performed and reconstitution of the BM was
veriﬁed. The following three primers were used at the same time,
as previously reported [10]: 5′-AGCAATGCACCTCCCTGCGAT-3′, 5′-
CTGCTCTTTACTGAAGGCTC-3′ and 5′-TCCTCGGTGGGATGAAGTCCA-
3′. PCR products of 124 bp were obtained for WT, WTWT-BM and
PTX3KOWT-BM mice, and 300 bp for PTX3KO, WTPTX3KO-BM and
PTX3KOPTX3KO-BM mice (Fig. 1).2.3. Myocardial ischemia and reperfusion
After conﬁrming BM reconstitution, mice were intubated with a 20-
gauge polyethylene catheter under general anesthesia (0.25 mg/g of
body weight, tribromoethanol) and positive-pressure ventilated with
a rodent ventilator (Shinano Manufacturing, Tokyo, Japan). The hearts
were exposed by left thoracotomy, and myocardial infarction was pro-
duced by suture occlusion of the left anterior descending coronary ar-
tery (LAD) over a silicon tube. After 45 min of ischemia, the tube and
suturewere removed to permit reperfusion. The heart was repositioned
in the chest, and the chest wall was closed with a silk suture.
2.4. Assessment of infarct size
Forty-eight hours after reperfusion, the LADwas occluded again at the
same position, and 1% Evans blue was injected via the inferior vena cava.
The heartwas then excised and sliced transversely into ﬁve to six sections
which were incubated with 1.5% triphenyltetrazolium chloride (TTC) for
30 min at 37 °C. The area lacking Evans blue staining was regarded as
the area at risk (AAR), and the white-colored (TTC-negative) area within
the AARwas considered the infarct area. The AARwas expressed as a per-
centage of the left ventricular mass (AAR/LV), and the infarct area was
expressed as a percentage of the AAR (infarct area/AAR). Area quantiﬁca-
tion was performed using Image J Software (NIH, Bethesda, MD).
2.5. Immunohistochemistry
For immunohistochemistry, the heart was excised 48 h after I/R and
immediately ﬁxed with 4% paraformaldehyde and embedded in paraf-
ﬁn. After deparafﬁnization, the 5 μm thick sections were treated with
0.3%H2O2 inmethanol for 30min anddigestedwith 100mg/ml protein-
ase K in 0.05 mol/l Tris–HCl (pH 7.6) for 10 min at room temperature.
After incubating with 5% skim milk, the sections were reacted with rat
anti-mouse GR-1 antibody (eBioscience, San Diego, CA) at 4 °C over-
night to identify neutrophils at the risk area. The sections were then
treated with horseradish peroxidase conjugated anti-rat IgG (Abcam,
Cambridge, MA) followed by coloration with 3,3′-diaminobenzidine
(Nichirei Biosciences, Inc., Tokyo, Japan) and counterstained with he-
matoxylin. Quantitative assessment of inﬁltrated neutrophils in the
area at risk was performed by counting the number of positive cells in
ﬁve different ﬁelds (1 mm2) of the ischemic border zones. The border
zone was deﬁned as surviving cardiomyocytes that were in close
308 T. Shimizu et al. / Journal of Molecular and Cellular Cardiology 89 (2015) 306–313contact with coagulative necrotic tissue, which was identiﬁed in sec-
tions of hematoxylin–eosin staining [12]. All measurements were per-
formed in a double-blind manner by two independent researchers.
For double immunoﬂuorescence, the heart was excised 48 h after
I/R, embedded in the OCT compound (Tissue-Tek; Miles Laboratories,
Elkhart, IN), then frozen in liquid nitrogen. The 8 μm thick sections
were incubated withmouse anti-human PTX3 antibody (Perseus Prote-
omics Inc., Tokyo, Japan) simultaneously with rat anti-mouse GR-1 an-
tibody (R&D Systems, Minneapolis, MN) for neutrophil, rat anti-mouse
F4/80 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) formac-
rophage, or goat anti-mouse CD31 (Santa Cruz Biotechnology) for endo-
thelial cells at 4 °C overnight. The anti-PTX3 reaction was developed
in green (Alexa® Fluor 488 conjugated goat anti-mouse antibody; Cell
Signaling Technology, Danvers, MA), GR-1 and F4/80 in red (Alexa®
Fluor 594 conjugated rabbit anti-rat antibody; Molecular Probes,
Eugene, OR) and CD31 also in red (Alexa® Fluor 594 conjugated donkey
anti-goat antibody; Molecular Probes). The samples were observed
using ﬂuorescence microscopy (Olympus IX71, OLYMPUS Optical Co.,
Tokyo, Japan) after nuclear counterstaining with 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Sigma-Aldrich, St. Louis, MO).
2.6. Enzyme-linked immunosorbent assay
Blood samples were collected from the retro-orbital plexus into the
plasma separation tube at 24h after I/R and immediately centrifuged. Pro-
teins were extracted from the snap-frozen left ventricle, which was
excised at 24 h after I/R with ice-cold lysis buffer, as previously reported
[13]. The protein concentrations in the myocardial samples were deter-
mined using a protein assay (Bio-Rad Laboratories, Inc., Hercules, CA).
The levels of interleukin-6 (IL-6) were assessed using the Mouse IL-6
ELISA Kit (RayBiotech, Inc., Norcross, GA) according to themanufacturer's
instructions.
2.7. Assay of reactive oxygen species
The excised heart tissue 48 h after I/R was immediately frozen in
liquid nitrogen with OCT compound (Tissue-Tek) and sectioned at 8-μmFig. 2. Enlargement of infarct size after myocardial I/R by the lack of PTX3 from bonemarrow-d
thewhole left ventricular transverse section (AAR/LV) and the infarct area (TTC negative) relati
Although no differencewas observed inAAR/LV among the four groups (A), the infarct area/AAR
recipient types, infarct area/AARwas greater inWTPTX3KO-BM than inWTWT-BM, and greater in P
the corresponding bars. Each bar representsmean±SE (n=9–12). *P b 0.05 and **P b 0.01 vs.W
the Tukey test.thickness. The section was incubated with 5 μmol/l of dihydroethidium
(DHE; Sigma-Aldrich) at 37 °C for 30 min in the dark. The ﬂuorescent
images were acquired using a ﬂuorescence microscope (Olympus IX71,
OLYMPUS Optical Co.) and the mean DHE ﬂuorescence intensity of
cardiomyocytes in the ischemic border areas, which of ﬁve randomly se-
lectedﬁelds in each section,was quantitatedwith Image J Software (NIH).
Oxidative DNA damage in the myocardium was evaluated by 8-
hydroxy-2′-deoxyguanosine (8-OHdG) immunostaining. After
deparafﬁnization, the sectionswere treatedwith 0.3% H2O2 inmethanol
for 30min at room temperature, and boiled in sodium citrate (pH 6.0) by
a microwave for 10min. After incubating with 5% skimmilk, the sections
were reactedwith anti-8-OHdGmonoclonal antibody (cloneN45.1, Japan
Institute for the Control of Aging, Fukuroi, Japan) for 1 h at room temper-
ature in a humidity chamber, followed by staining with peroxidase-
labeled secondary antibodies (Histoﬁne Simple Stain Mouse MAX PO,
Nichirei Biosciences, Inc.) and 3,3′-diaminobenzidine (Nichirei Biosci-
ences, Inc.). The sections were then counterstained with hematoxylin.
For co-staining with DHE and ROS-generating cells, frozen sections
were incubated with mouse anti-α actinin antibody (Sigma-Aldrich)
>for cardiomyocyte, rabbit anti-mouse CD31 (Santa Cruz Biotechnology)
for vascular endothelial cells and rabbit anti-S100A4 antibody (Abcam)
for ﬁbroblast. The primary antibody reactions were developed in green
(Alexa® Fluor 488 conjugated goat anti-mouse antibody; Cell Signaling
Technology, and Alexa® Fluor 488 conjugated goat anti-rabbit antibody;
Abcam), followed by counterstaining with DAPI and DHE staining as de-
scribed above.
2.8. Ultra performance liquid chromatography
Dihydroethidium oxidation generates at least two ﬂuorescent
products; 2-hydroxyeyhidium, which is more speciﬁc for superoxide,
and ethidium, which reﬂects H2O2-dependent pathways involving
metal proteins [14]. We performed ultra performance liquid chroma-
tography (UPLC) to separate and quantify these products and to esti-
mate superoxide in the heart tissue after I/R [15]. The excised heart
tissue 48 h after I/R was immediately cut into 20 mg from left ventricu-
lar apex and incubated with Krebs-HEPES buffer containing 50 μM oferived cells. Quantitativemeasurement of AAR (Evans blue negative) relative to the area of
ve to AARwas performed inmice after 45min of ischemia followed by 48 h of reperfusion.
was signiﬁcantly greater in PTX3KOPTX3KO-BM than inWTWT-BM. In comparison of the same
TX3KOPTX3KO-BM than in PTX3KOWT-BM (B). Representative cross sections are shown below
TWT-BM, ##P b 0.01 vs. PTX3KOWT-BM. Datawere analyzed by one-way ANOVA followed by
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Krebs-HEPES buffer, subsequently placed in 300 μl of coldmethanol and
homogenized. The solution was exsiccated by nitrogen gas, dissolved in
100 μl of 0.2% formic acid, and ﬁltered (0.22 μm). The ﬁltrate was then
analyzed by UPLC as described below.
Separation of 2-hydroxyethidium, ethidium and DHE was performed
using aWaters AQUITY UPLC H-class systemwith a AQUITY BEH C18 col-
umn (particle size 1.7 μm, ф 2.1 × 50 mm,Waters, Milford, MA) at 40 °C.
The samples were separated using an isocratic mobile phase consisting of
0.2% formic acid and acetonitrile (80:20, v/v) at a ﬂow rate of 0.5 ml/min.
DHE was monitored by ultraviolet absorption at 355 nm, and 2-
hydroxyethidium was monitored by ﬂuorescence detection at 480 nm
(excitation) and 580 nm (emission). Generation of 2-hydroxyethidium
was expressed as a ratio of integrated peak area per DHE consumed (ini-
tial DHE concentration minus remaining DHE).
2.9. Statistical analysis
All resultswere distributed normally and expressed asmean± stan-
dard error (S.E.). Statistical signiﬁcance was evaluated using one-way
analysis of variance (ANOVA) for comparisons among four groups,
followed by multiple comparisons with the Tukey test. A P value of
less than 0.05 was considered to be statistically signiﬁcant. These
analyses were performed using a statistical software package (SPSS
ver. 21.0, IBM, Armonk, NY).Fig. 3. PTX3 expression in neutrophils, macrophages and endothelial cells after myocardial I/R.
immunoﬂuorescence stainingwith antibodies against PTX3 andGR-1 (neutrophils), F4/80 (mac
inWTWT-BM (A) and PTX3KOWT-BM (C), and endothelial cells inWTWT-BM (A) andWTPTX3KO-BM (
in images of neutrophils and macrophages, 40 μm in endothelial cells.3. Results
3.1. Enlargement of infarct size aftermyocardial I/R by the lack of PTX3 from
bone marrow-derived cells
To investigate whether PTX3 produced from BM-derived cells con-
tributes to myocardial I/R injury, the myocardial I/R procedure was
performed on four types of BM transplantation mice. Although no
difference was observed in AAR/LV among the four groups (Fig. 2A),
the infarct area/AAR was signiﬁcantly greater in PTX3KOPTX3KO-BM
than in WTWT-BM (73.5 ± 2.4 vs. 49.3 ± 3.2, P b 0.01) (Fig. 2B). In
comparison of the same recipient types, infarct area/AAR was greater
in WTPTX3KO-BM than in WTWT-BM (62.8 ± 3.7 vs. 49.3 ± 3.2%, P b 0.05),
and greater in PTX3KOPTX3KO-BM than in PTX3KOWT-BM (73.5 ± 2.4 vs.
57.0 ± 3.4%, P b 0.01). No signiﬁcant difference was observed between
WTWT-BM and PTX3KOWT-BM (P= 0.43).
3.2. PTX3 expression in neutrophils, macrophages and endothelial cells
We next assessed the cellular distribution of PTX3 by double immu-
noﬂuorescence of PTX3 and neutrophils (anti-GR-1 antibody), macro-
phages (anti-F4/80 antibody) or endothelial cells (anti-CD31 antibody)
in the ischemic myocardium. In WTWT-BM mice, PTX3 was localized
in neutrophils, macrophages, and endothelial cells, but not in the
cardiomyocytes (Fig. 3A). In WTPTX3KO-BM mice, PTX3 was localizedAfter 48 h from reperfusion, the sections of the ischemic areas were analyzed by double-
rophages) or CD31 (endothelial cells). PTX3was localized in neutrophils andmacrophages
B). PTX3 expressionwas not identiﬁed in PTX3KOPTX3KO-BM (D). Scale bars represent 10 μm
Fig. 4. Increment of neutrophil inﬁltration into the ischemic myocardium after myocardial I/R by the lack of PTX3 from bone marrow-derived cells. The sections of ischemic border zones,
deﬁned as surviving cardiomyocyteswhichwere in close contactwith coagulative necrotic tissue (A),were stainedwith anti-GR-1 antibody to visualize inﬁltration of neutrophils andquan-
titative assessment of inﬁltrated neutrophils was performed (B). GR-1 positive cells in the ischemic border zones were greater in PTX3KOPTX3KO-BM than in WTWT-BM and PTX3KOWT-BM.
Data are expressed as mean ± SE (n = 5 for each). **P b 0.01 vs. WTWT-BM, ##P b 0.01 vs PTX3KOWT-BM. Data were analyzed by one-way ANOVA followed by the Tukey test.
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was localized in neutrophils and macrophages, but not in endothelial
cells (Fig. 3C). PTX3 expression was not identiﬁed in PTX3KOPTX3KO-BM
mice (Fig. 3D).
3.3. Increment of neutrophil inﬁltration and interleukin-6 expression after
myocardial I/R by the lack of PTX3 from bone marrow-derived cells
It has been reported that neutrophils contribute to the myocardial
I/R injury, and the extent of infarct size aftermyocardial I/R is correlatedFig. 5. Increment of plasma and cardiac expression of IL-6 inmyocardial I/R injury by the lack of
assessed. IL-6 level was signiﬁcantly higher in PTX3KOPTX3KO-BM comparedwithWTWT-BM and P
in PTX3KOPTX3KO-BM comparedwithWTWT-BM and PTX3KOWT-BM. Data are expressed asmean±
by one-way ANOVA followed by the Tukey test.with an increase in the population of accumulated neutrophils [16].
Therefore, to compare the inﬁltration of neutrophils into ischemic myo-
cardium in each type of mice, immunohistochemical analysis using anti-
GR-1 antibodywas performed (Fig. 4). GR-1 positive cells in the ischemic
border zone were greater in PTX3KOPTX3KO-BM than in WTWT-BM and
PTX3KOWT-BM (467.2 ± 34.1 vs. 312.5 ± 31.7 and 298.2 ± 25.2/mm2,
P b 0.01). No signiﬁcant deference was observed between WTWT-BM
and PTX3KOWT-BM (P= 0.98).
To investigatewhether inﬂammatory cytokines are involved in the in-
crement of myocardial I/R injury in PTX3KOPTX3KO-BM and WTPTX3KO-BMPTX3 from bonemarrow-derived cells. (A) Plasma levels of IL-6 at 24 h of reperfusionwere
TX3KOWT-BM. (B)Myocardial levels of IL-6were assessed. IL-6 level was signiﬁcantly higher
SE (n=7 for each). *P b 0.05 vs.WTWT-BM, #P b 0.05 vs PTX3KOWT-BM. Datawere analyzed
Fig. 6. Increment of oxidative stress aftermyocardial I/R by the lack of PTX3 frombonemarrow-derived cells. The sections of ischemic border zoneswere stainedwith DHE to visualize ROS
levels of myocardium (A) andwith anti 8-OHdG antibody to evaluate oxidative DNA damages (B). Relative ﬂuorescence intensity was higher in PTX3KOPTX3KO-BM andWTPTX3KO-BM than in
WTWT-BM, and lower in PTX3KOWT-BM than in PTX3KOPTX3KO-BM (A). A ratio of 8-OHdGpositivenuclei/total cells in ischemicborder areaswas increased in PTX3KOPTX3KO-BM andWTPTX3KO-BM
compared with WTWT-BM, and lower in PTX3KOWT-BM compared with PTX3KOPTX3KO-BM (B). In the superoxide quantiﬁcation by UPLC, peak integral area of 2-hydroxyethidium per DHE
was higher in PTX3KOPTX3KO-BM and WTPTX3KO-BM compared with WTWT-BM, and lower in PTX3KOWT-BM compared with PTX3KOPTX3KO-BM (C). Representative images are shown below
the corresponding bars. Each bar representsmean±SE (n=5 for each (A) (B), and n=8 for each (C)). *P b 0.05 and **P b 0.01 vs.WTWT-BM, #P b 0.05 vs. PTX3KOWT-BM. Datawere analyzed
by one-way ANOVA followed by the Tukey test.
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at 24 h after reperfusion (Fig. 5). IL-6 was signiﬁcantly higher in
PTX3KOPTX3KO-BM compared with WTWT-BM and PTX3KOWT-BM in both
plasma (0.80 ± 0.27 vs. 0.15 ± 0.03 and 0.09 ± 0.01 ng/ml, P b 0.05)
andmyocardial levels (14.8± 3.6 vs. 6.6 ± 0.8 and 5.9± 0.9 pg/mg pro-
tein, P b 0.05), while no signiﬁcant difference was observed between
WTWT-BM and PTX3KOWT-BM (P= 0.86).
3.4. Increment of oxidative stress after myocardial I/R by the lack of PTX3
from bone marrow-derived cells
Reactive oxygen species are greatly increased in the post-ischemic
heart and serve as a central mechanism of myocardial I/R injury [17].
We evaluated cardiac ROS generation by DHE ﬂuorescence (Fig. 6A).
The ROS generation in the ischemic border zones at 48 h of reperfusion
was higher in PTX3KOPTX3KO-BM and WTPTX3KO-BM than in WTWT-BM
(28.7 ± 2.1 and 21.8 ± 4.6 vs. 12.0 ± 1.8, P b 0.01 and P b 0.05, respec-
tively), which alsowas lower in PTX3KOWT-BM than in PTX3KOPTX3KO-BM
(16.4 ± 3.2 vs. 28.7 ± 2.1, P b 0.05). No signiﬁcant difference was ob-
served betweenWTWT-BM and PTX3KOWT-BM (P= 0.52).
Oxidative DNA damage in the reperfused myocardium was evalu-
ated by 8-OHdG immunostaining. The 8-OHdG positive nuclei were ob-
served in ischemic cardiomyocytes (Fig. 6B), and a ratio of 8-OHdG
positive nuclei/total nuclei in ischemic border zones was higher in
PTX3KOPTX3KO-BM and WTPTX3KO-BM than in WTWT-BM (48.3 ± 2.4 and
44.3 ± 2.2 vs. 25.8 ± 2.2%, P b 0.01) and lower in PTX3KOWT-BM
than in PTX3KOPTX3KO-BM (33.5 ± 1.7 vs. 48.3 ± 2.4%, P b 0.01). No sig-
niﬁcant difference was observed between WTWT-BM and PTX3KOWT-BM
(P= 0.46).
We also measured 2-hydroxyethidium (2OH-E), which is formed in
the reaction of DHE with superoxide, by UPLC (Fig. 6C). Peak integral
area of 2OH-E per consumed DHE was higher in PTX3KOPTX3KO-BMFig. 7. PTX3 affected ROS in cardiomyocytes, but not in vascular endothelial cells and ﬁbrob
WTPTX3KO-BM and PTX3KOPTX3KO-BM than in WTWT-BM and PTX3KOWT-BM. On the other hand,
four types of mice, indicating that PTX3 has not contributed to generation of ROS from endothan in WTWT-BM (907.4 ± 39.3 vs. 530.4 ± 87.1 μVs/μM, P b 0.05). In
comparison of the same recipient types, superoxide generation
was greater in WTPTX3KO-BM than in WTWT-BM (840.3 ± 48.3 vs.
530.4 ± 87.1 μVs/μM, P b 0.05), and greater in PTX3KOPTX3KO-BM than in
PTX3KOWT-BM (907.4 ± 39.3 vs. 578.9 ± 116.7 μVs/μM, P b 0.05). No sig-
niﬁcant difference was observed between WTWT-BM and PTX3KOWT-BM
(P= 0.97) or WTPTX3KO-BM and PTX3KOPTX3KO-BM (P= 0.93).
3.5. Differences of ROS generation by the lack of PTX3 from bone marrow-
derived cells appeared in cardiomyocytes, but not in endothelial cells or
ﬁbroblasts
To examine potential mechanism of increased generation of ROS
in mice with BM from PTX3KO donor mice (WTPTX3KO-BM and
PTX3KOPTX3KO-BM), we performed DHE staining subsequent to immu-
noﬂuorescence of cardiomyocytes (anti-α actinin antibody), vascular
endothelial cells (anti-CD31 antibody) and ﬁbroblasts (anti-S100A4
antibody) (Fig. 7).
DHE ﬂuorescence intensity of myocardium was higher in mice with
BM from PTX3KO donor mice (WTPTX3KO-BM and PTX3KOPTX3KO-BM) than
in mice with BM from WT donor mice (WTWT-BM and PTX3KOWT-BM).
On the other hand, DHE ﬂuorescence intensity of endothelial cells and
ﬁbroblast did not differ among four types of mice, indicating that
PTX3 has not contributed to generation of ROS from endothelial cells
and ﬁbroblasts.
4. Discussion
This study demonstrates that deﬁciency of PTX3 produced fromBM-
derived cells, and not from cardiac resident cells, increases myocardial
infarct size after I/R inmice. In addition, deﬁciency of PTX3 increases in-
ﬁltration of neutrophils to the ischemic area, plasma levels and cardiaclasts. DHE ﬂuorescence intensity of myocardium at ischemic border zone was higher in
DHE ﬂuorescence intensity of endothelial cells and ﬁbroblasts did not differ among the
thelial cells and ﬁbroblasts. Scale bars represent 10 μm.
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Thus, these data indicate a cardio-protective role of PTX3produced from
BM-derived cells inmyocardial I/R-induced inﬂammation and oxidative
stress.
Although neutrophils play an important role in the healing process
after myocardial infarction, they contribute to myocardial I/R injury by
several mechanisms such as the release of ROS and proteases [18], em-
bolization in microvessels leading to the no-reﬂow phenomenon [19],
and the release of inﬂammatory mediators which ampliﬁes further
recruitment of neutrophils into the reperfused myocardium [20]. Ac-
cordingly, the extent of the infarct size in myocardial I/R injury has
been correlated with an increase in the population of accumulated neu-
trophils [16]. Examinations for inhibiting neutrophil in animal models
have been performed by a large number of researchers using several
approaches; leukocyte depletion, antibodies to adhesion molecules,
anti-inﬂammatory agents, adenosine, protease inhibitors, and local anes-
thetics, showing enhanced recovery of contractile function or reduction
of infarct size after I/R [4]. PTX3, which is stored in speciﬁc granules of
neutrophils and released in response to inﬂammatory signals [21], has
been reported to increase in the early phase of acute myocardial infarc-
tion [22]. Regarding the function of PTX3 in inﬂammation, Deban et al.
[23] reported that PTX3 released from activated leukocytes functioned
locally to attenuate neutrophil recruitment at the site of inﬂammation
by binding selectively with P-selectin, which functions as a cell adhesion
molecule on the surface of activated endothelial cells and platelets.
According to this leukocyte modulating function of PTX3, lack of PTX3
has led to increased myocardial damage after I/R. Although Salio et al.
[7] described larger infarct size and greater neutrophil inﬁltration in re-
perfused myocardium in PTX3-deﬁcient mice compared with WT mice,
the origins of PTX3 functioning for protection ofmyocardiumwasnot ob-
vious. Our experiments revealed that PTX3 produced from BM-derived
leukocytes, but not from cardiac vascular endothelial cells, functioned
to attenuate I/R-induced neutrophil inﬁltration and myocardial injury.
Reactive oxygen species are produced in myocardial I/R, and several
reports demonstrated that inhibiting formation of ROS could reduce
infarct size [24]. Three major enzyme pathways were identiﬁed as the
source of ROS production in I/R injury: (1) xanthine oxidase, primarily
within endothelial cells; (2) the mitochondrial electron transport
chain, primarily from the cardiomyocytes; (3) NADPH oxidase, primar-
ily with leukocytes and ﬁbroblasts [17]. We have showed the lack of
PTX3 produced from leukocytes induced increased ROS generation in
the damaged myocardium after I/R, but not in vascular endothelial
cells or ﬁbroblasts. Althoughwe could not exclude a direct link between
PTX3 and generation of ROS inmyocardium, our data indicate that PTX3
participates in ROS reduction by attenuating their recruitment into
reperfused myocardium. The increased generation of free radicals and
oxidants from neutrophils by lack of PTX3 is not an only pathologic
cause in myocardial I/R; larger magnitude of neutrophil inﬁltration
leads to a greater degree of no-reﬂow phenomenon as Salio et al. [7]
described, but it critically contributes to the increased damages of
cardiomyocytes after I/R.
Future studies are required to explore the effects of anti-neutrophil
and antioxidant therapy in this model to verify the results in this
study, which is a limitation of the present study.
5. Conclusion
We demonstrated that PTX3 produced from bone marrow-derived
cells inhibited inﬁltration of neutrophils and ROS generation at the is-
chemic myocardium, thereby resulting in the reduction of infarct size
after ischemia–reperfusion.
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